50 and older, any sex, with Social Isolation or Loneliness. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Perceived AutonomyPrimary· two weeks
This is a self-report measure that assesses a mechanism posited by Self-Determination Theory to increase motivation for healthy behaviors. It has 6 items, a range from 6-30, and higher scores indicate greater perceived autonomy.
Group
Value
95% CI
Connect for Caregivers
21.2
± 1.32
Perceived Competence ScalePrimary· two weeks
This is a self-report measure that assesses a mechanism posited by Self-Determination Theory to increase motivation for healthy behaviors. It has 7 items, a range from 7-35, and higher scores indicate greater perceived competence.
Group
Value
95% CI
Connect for Caregivers
16.4
± 2
Knowledge of Social EngagementSecondary· two weeks
This is a self-report measure that assesses a subject's knowledge of the importance of social connections. It has 4 items, a range from 4-20, and higher scores indicate greater knowledge.
Group
Value
95% CI
Connect for Caregivers
15.6
± 2.3
LonelinessSecondary· two weeks
UCLA Loneliness Scale Version 3, which assesses self-reported loneliness. 20 items, rated as to how often the participant has felt a certain way in the prior month (e.g., "How often do you feel alone?") -- "never" (1), "rarely" (2), "sometimes" (3), or "often" (4). Higher scores indicate greater loneliness. Total scores range from 20 to 80, with higher scores representing a worse outcome (i.e., greater loneliness).
Group
Value
95% CI
Connect for Caregivers
53.4
± 6.11
Sponsor's own description
Connect for Caregivers is a intervention feasibility pilot study. The purpose of the study is to pilot test a newly developed single session behavioral intervention to help caregivers of individuals with Alzheimer's Disease or related dementias gain understanding of the importance of increasing social connectedness, awareness of their personal barriers to connectedness, and knowledge of local resources for promoting connectedness.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT05812989 — Modifiers and Mechanisms of Loneliness Interventions
· NA
· completed
NCT04593628 — Connection for Latinos Caring for a Loved One With Dementia
· NA
· withdrawn
Other recruiting trials for Social Isolation
Currently open trials in the same condition.
NCT06803329 — Qnnections: Refinement and Pilot Trial of a Suicide Prevention Intervention to Increase Social Connection
· NA
· recruiting
NCT07107906 — Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Lone
· NA
· recruiting
NCT07089914 — Health Surveillance at University of Applied Science Hamburg (HAW)
· active not recruiting
NCT06510439 — Need to be Needed (N2BN) Intervention
· NA
· recruiting
NCT06467214 — Increasing Veterans' Social Engagement and Connectedness
· NA
· recruiting
Other University of Rochester trials
Trials by the same sponsor.
NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1
· Phase 1
· not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi
· Phase 2
· not yet recruiting
NCT05744869 — SBAT for Health Equity
· NA
· not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
· Phase 2
· not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 29 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04919070.